News

Nephros Joins Benchmark Company Conference to Connect with Investors

Nephros Joins Benchmark Company Conference to Connect with Investors

Nephros to Engage with Investors at Annual Conference

Nephros, Inc. (NASDAQ: NEPH), a pioneering company focused on water technology, has announced its participation in the esteemed Benchmark Company Annual Discovery One-on-One Investor Conference. This event is a significant opportunity for Nephros to connect with potential investors and showcase its cutting-edge filtration solutions designed for both the medical and commercial markets.

Details About the Upcoming Conference

The Benchmark Company conference is set to take place at a prestigious venue in New York City, creating an ideal platform for Nephros to engage directly with institutional and individual investors. Representing Nephros at the event will be Robert Banks, the CEO, alongside Judy Krandel, the CFO. They will be coordinating both one-on-one and group meetings with interested investors to discuss the company’s growth and strategies.

How to Schedule a Meeting

Investors eager to schedule a one-on-one meeting with Nephros during the conference can do so by registering early. This approach ensures a dedicated time slot to delve deeper into the innovative solutions that Nephros offers, as well as discuss potential collaborations.

The Significance of the Benchmark Company Conference

The Benchmark Company Annual Discovery Conference is a well-respected event that fosters relationships between dynamic publicly traded companies and a diverse array of investors. This format provides Nephros with a unique opportunity to engage in meaningful discussions about its future, its innovative technologies, and how it continues to enhance water safety solutions.

Who is The Benchmark Company?

The Benchmark Company is known for its strong focus on institutional investment and research-driven services. Established in 1988 and based in New York City, the firm is dedicated to supporting corporate clients in raising capital and executing strategic plans that promote long-term success. By leveraging its extensive network in sales, trading, and equity research, The Benchmark Company serves as a vital resource for companies looking to expand their market positions.

Nephros and Its Commitment to Water Safety

At its core, Nephros is dedicated to enhancing the relationship humans have with water through innovative and accessible technology. The company prides itself on providing advanced water filtration products, designed to cater to the healthcare and commercial sectors. In addition to offering emergency and proactive water management solutions, Nephros emphasizes water-quality education, empowering customers to make informed decisions regarding water safety.

Innovative Solutions from Nephros

The products from Nephros are not just about filtration; they represent a holistic approach to water management and safety. The company continues to invest in research and development to ensure its solutions meet the evolving demands of the marketplace while addressing public health concerns surrounding water quality.

Investor Relations Contact Information

For further information or specific inquiries, investors can reach out to Nephros's investor relations contacts. Kirin Smith, the president of PCG Advisory, is available at (646) 823-8656 and via email at ksmith@pcgadvisory.com. Additionally, Robert Banks, the CEO of Nephros, can be reached at (201) 343-5202 x110 or through his official email address.

Frequently Asked Questions

What is the purpose of the Benchmark Company Conference?

The conference aims to connect emerging growth companies like Nephros with potential investors for in-depth discussions regarding business strategies and innovations.

Who will represent Nephros at the conference?

Robert Banks, the CEO, and Judy Krandel, the CFO, will represent Nephros during the Investor Conference.

How can investors schedule a meeting with Nephros?

Investors can schedule meetings by registering for the conference and indicating their interest in one-on-one discussions with Nephros representatives.

What does Nephros specialize in?

Nephros specializes in providing innovative water filtration solutions tailored for both medical and commercial applications.

How can I contact Nephros for more information?

Investors can reach out via the investor relations contacts provided, or visit Nephros's official website for more details.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Synova Global Taps Eventus for Top Trade Surveillance

Updated Category News Views 144

Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...

Continue Reading
Cambiotics Launches Key Trial on Reducing PFAS in Firefighters

Updated Category News Views 44

Pioneering Efforts to Combat 'Forever Chemicals' Cambiotics is stepping into some uncharted territory—tackling the tricky problem of PFAS accumulation in firefighters. If you’ve been following this, PFAS, or per- and polyfluoroalkyl substances, have been living rent-free in our bodies for years. Used in firefighting equipment and foams, these chemicals stick around,...

Continue Reading
ZBS Group Takes Over Rabinowitz’s CPA Practice with Bold Moves

Updated Category News Views 44

Transitioning Power in the CPA World Let's cut to the chase—when a seasoned CPA like Joseph Rabinowitz picks up the phone to secure a succession partner, it's a big deal. Enter ZBS Group LLP, steered by Michael Zaidman, which isn't a stranger to these waters, undertaking their fourth CPA practice acquisition through Rabinowitz's corner of the accounting universe....

Continue Reading
Connecting NIH Data: Transforming Scientific Discoveries

Updated Category News Views 44

Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...

Continue Reading
Cerbo's AI Scribe Expands to Telehealth Success

Updated Category News Views 46

Cerbo Enhances Telehealth With AI Scribe Expansion The digital healthcare playground looks like it's getting a nudge toward efficiency with Cerbo's latest move. Just when you thought telehealth couldn't get much sharper, these folks have drawn a line in the sand with their AI Scribe, which now makes its presence felt in virtual visits. No more juggling a dozen screens...

Continue Reading
SportsMed Expands to 58 Clinics, New Opening in Jersey City

Updated Category News Views 28

SportsMed Physical Therapy Expands with New Clinic Well, here we are, talking about expansion. And not just any expansion—I'm talking about SportsMed Physical Therapy flexing its muscles in Jersey City Heights, boosting their count to 58 clinics scattered across New Jersey and Connecticut. It's like watching a network of care roots spreading deeper into the region, and...

Continue Reading
Geopolitical Talks Shake Oil Market, Refine Stocks' Path

Updated Category News Views 92

Diplomacy Takes Center Stage So here we are again, riding the rollercoaster of geopolitics that's jerking the oil market around like a marionette. With the U.S. and Iran allegedly chatting—mind you, with a ton of smoke and mirrors through Qatar and Islamabad—every trader's watching, hoping for a ceasefire that might either stabilize or further jolt energy prices. Oil...

Continue Reading
Linker Vision's AI Platform Boosts Urban Planning

Updated Category News Views 72

Now, I've seen a fair share of tech rollouts claiming to change the world, but Linker Vision’s new AI platform, Linker AI Nexa, might actually be onto something real here. Revealed at the Smart City Expo World Congress 2026 in Barcelona, this isn't just another pretty interface—it’s packing some serious firepower with NVIDIA tech. Bringing Physical AI to City...

Continue Reading
Bright Minds Faces Legal Scrutiny Over FDA Trial Hold

Updated Category News Views 72

Bright Minds Biosciences Under the Microscope Well, it looks like Bright Minds Biosciences has found itself in some hot water with investors. After the FDA put a partial hold on their Phase 2 trial for BMB-101, designed for epilepsy treatment, the stock took a nosedive. If you're holding a piece of NASDAQ:DRUG, or even if you cut your losses and ran, it's time to tune in....

Continue Reading
Instanodes Tackling Quantum Threats in Blockchain

Updated Category News Views 114

Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...

Continue Reading

Top 5 Most Recently Viewed Articles

MindMaze Therapeutics: 2026 Business Update and Insights

Updated Category News Views 16

Breaking Down MindMaze’s 2026 Update Today, I’m sifting through MindMaze Therapeutics' latest half-year report like a prospector panning for gold nuggets. It’s a mixed bag, folks, full of expansion optimism underlined by a nagging loss in the financial ledger. But they say fortune favors the bold, right? The company has ambitious ideas, and their genetic makeup...

Continue Reading
Tantrum Sportfishing Celebrates Record Blue Marlin Achievement

Updated Category News Views 190

Historic Milestone for Tantrum Sportfishing In an inspiring turn of events for the sportfishing community, Tantrum Sportfishing has achieved a remarkable milestone. The Kona-based charter company announced its proud entry into the illustrious "Grander Club" after landing a colossal 1,039-pound Blue Marlin. This catch not only signifies a personal triumph for the team but...

Continue Reading
New Bitcoin ETF Offers Investors Unique Downside Protection

Updated Category News Views 227

Calamos Introduces a Groundbreaking Bitcoin ETF Investment management firm Calamos is excited to roll out an innovative approach to cryptocurrency investing with the launch of the world’s first 100% downside-protected Bitcoin exchange-traded fund (ETF). This launch comes just after an announcement suggesting that an ETF will be available for investors looking to...

Continue Reading
Exciting Developments in dsm-firmenich's Share Repurchase Initiative

Updated Category News Views 178

Progress Update on dsm-firmenich's Share Repurchase Program dsm-firmenich, known for its innovative approach in the fields of nutrition, health, and beauty, is actively implementing its large-scale share repurchase program. This initiative began earlier this year and signifies a strategic move to enhance shareholder value and manage capital effectively. Initial...

Continue Reading
Capricor Therapeutics: Key Deadlines for Shareholders to Remember

Updated Category News Views 133

Crucial Dates for Capricor Therapeutics Shareholders The Gross Law Firm has released an important notice for shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR). The firm encourages anyone who purchased shares during the specified class period to connect with them regarding possible lead plaintiff appointments. Being appointed as the lead plaintiff isn't necessary...

Continue Reading